MK-2866

most data

Also seen as: Ostarine, enobosarm, Enobosarm

The Dose Guy’s verdict
Sep 1, 2026
3 sources

Ostarine is the SARM that makes sense. It has real human trial data, the mildest suppression in the class, and a side profile that does not demand steroid-level vigilance. If someone asks me which SARM to run, this is the answer, and the only one I would point a first-timer toward. The honest catch: you are still buying from an unregulated market, the capsule is not always what the label says, and mild does not mean free.

Would I take it?Yes, the sensible one.

What it is

Ostarine is a nonsteroidal selective androgen receptor modulator, meaning it activates the androgen receptor in muscle and bone while mostly leaving other tissues alone. It was developed for muscle wasting and frailty, and it made it through phase 2 trials and into phase 3, which is more than most SARMs can say. It still never got approved. The mechanism is the same family as RAD-140 and LGD-4033, but ostarine sits at the mild end: weaker anabolic signal, less suppression, fewer sides.

That mildness is the feature. Ostarine is not the SARM that builds the most mass. It is the one that gives a useful recomp, holds muscle on a cut, or bridges between cycles, without demanding the same recovery commitment as the stronger options. For people who want the effect of a SARM and not the aftermath of a steroid, this is where the math works.

What the research shows

Ostarine has more human data than the rest of the SARM shelf combined. Real randomized trials, real endpoints, real numbers:

A 12-week trial in 120 healthy older adults found dose-dependent increases in total lean body mass, significant for 3 mg versus placebo with p under 0.001, and improved physical function with p=0.013.J Cachexia 2011 · phase 2 RCT · n=120
In cancer patients losing muscle, 1 mg daily increased total lean body mass from baseline by a median 1.5 kg by day 113 or study end. The placebo arm gained 0.02 kg over the same period.Lancet Oncol 2013 · phase 2 RCT · n=159
A vial labeled 25 mg/mL of ostarine measured at 17 mg/mL. In the same study, ostarine showed up at 0.3 to 13 ng/mL in the urine of a person exposed only through normal close contact including kissing.Clin Chim Acta 2024 · transfer study

Realistic protocols

Most people run ostarine at 15 to 25 mg a day, orally, for eight to twelve weeks. The sweet spot for a first run is 15 to 20 mg. Ostarine’s ceiling is lower than the aggressive SARMs, and pushing past 25 mg mostly buys more suppression without a proportional gain.

For a recomp or cut, keep protein high and training consistent. Ostarine holds muscle while you diet down, but it is not magic, and a trash diet wastes the window. For a bridge between anabolic cycles, 10 to 15 mg is enough to hold tissue while the body recovers.

Suppression is real but mild. Most people notice it around weeks six through eight, and for many it resolves on its own within a month after stopping. If bloodwork after the cycle shows testosterone still flat, a short PCT with a SERM like nolvadex cleans it up. A full heavy PCT the way you would after RAD-140 or LGD-4033 is usually overkill here.

Ostarine is WADA-banned. If you or anyone close to you competes in a tested sport, know that ostarine transfers through skin contact and kissing at concentrations that trigger a positive test.

Skip the alcohol while you are on. The liver injury cases are in healthy young men, and adding drinks on top of a compound that already stresses liver enzymes turns a mild risk into a real one.

A third-party COA is essential. The SARM market is unregulated and the capsule might not be ostarine, or not at the dose on the label. One tested vial labeled 25 mg/mL measured at 17 mg/mL.

Weeks 1–1215–25 mg/dayOral, once daily. 15–20 mg is plenty for a first run. Eight weeks is enough for most.
Recomp or cut15–20 mg/dayKeep protein at 1 g/lb and train hard. The SARM holds the muscle; you do the work.
Bridge10–15 mg/dayBetween cycles, enough to hold tissue while the body recovers.
PCT if neededNolvadex 10 mg or enclomiphene 6.25 mgOnly if post-cycle bloodwork shows flat testosterone. Often not needed.

Side effects

Mildest of the SARMs, but not free:

commonMild testosterone suppression, usually noticeable by week six to eight. Most people recover naturally within a month of stopping.
monitorHDL can dip. Run a lipid panel after the cycle and give it time to come back before starting another.
monitorLiver injury is rare at community doses but documented in healthy young men. If you feel off, check liver enzymes.
anecdotalSome users report mild hair shedding, usually temporary and dose-related.

Where to buy

$74.99 / unit
⚠ ⚠ Unreachable since Sep 11
✓ verified Sep 8

Prices move. Links are affiliate links; they never change a ranking, and scores are set before the deal exists.